Search results
Biotech With 345% Run Posts A 'Clear Win' In Cancer Treatment
Investor's Business Daily· 5 days agoThe company tested its treatment, dubbed NX-5948, in patients with relapsed or refractory forms of...
Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval
Investor's Business Daily· 20 hours agoThe gene therapy, dubbed Elevidys, already had accelerated approval for children age 4 and 5 with the muscle-wasting disease. Late Thursday, the Food and Drug Administration gave Elevidys a ...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 5 days agoNovavax’s filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine manufacturers Moderna (MRNA Quick QuoteMRNA - Free Report) , Novavax and Pfizer< ...